The Food and Drug Administration will hold a meeting of its Digital Health Advisory Committee on Nov. 20-21, according to a notice published in the Federal Register.
The purpose of the meeting is to discuss premarket performance evaluation, risk management, and postmarket performance monitoring for generative AI-enabled devices, according to the notice.
FDA Advisory Panel to Discuss AI-Enabled Medical Devices
bgov.com
September 17, 2024 10:36 am
The Food and Drug Administration will hold a meeting of its Digital Health Advisory Committee on Nov. 20-21, according to a notice published in the Federal Register.
The purpose of the meeting is to discuss premarket performance evaluation, risk management, and postmarket performance monitoring for generative AI-enabled devices, according to the notice.